Science Applications International Corporation
Cash Flow Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $358.0M | $362.0M | $477.0M | $300.0M | $277.0M | $209.0M | $226.0M | $137.0M |
| Depreciation & Amortization | $30.0M | $25.0M | $26.0M | $32.0M | $37.0M | $32.0M | $36.0M | $23.0M |
| Depreciation | $30.0M | $25.0M | $26.0M | — | — | — | — | — |
| Amortization | $119.0M | $115.0M | $115.0M | $125.0M | $128.0M | $147.0M | $95.0M | $24.0M |
| Stock-Based Compensation | $64.0M | $53.0M | $68.0M | $48.0M | $46.0M | $42.0M | $37.0M | $45.0M |
| Net Cash from Operating Activities | $609.0M | $494.0M | $396.0M | $532.0M | $518.0M | $755.0M | $458.0M | $184.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $32.0M | $36.0M | $27.0M | $25.0M | $36.0M | $46.0M | $21.0M | $28.0M |
| Business Acquisitions | $203.0M | $0 | $0 | $0 | $255.0M | $1.20B | $0 | $1.00B |
| Net Cash from Investing Activities | $-248.0M | $-35.0M | $314.0M | $-36.0M | $-292.0M | $-1.23B | $-47.0M | $-1.03B |
| Financing Activities | ||||||||
| Dividends Paid | $70.0M | $75.0M | $79.0M | $83.0M | $86.0M | $87.0M | $87.0M | $53.0M |
| Stock Repurchases | $445.0M | $558.0M | $382.0M | $267.0M | $226.0M | $34.0M | $197.0M | $69.0M |
| Net Cash from Financing Activities | $-235.0M | $-498.0M | $-725.0M | $-493.0M | $-301.0M | $464.0M | $-455.0M | $938.0M |
| Net Change in Cash | $126.0M | $-39.0M | $-15.0M | $3.0M | $-75.0M | $-12.0M | $-44.0M | $94.0M |
| Free Cash Flow | $577.0M | $458.0M | $369.0M | $507.0M | $482.0M | $709.0M | $437.0M | $156.0M |